Home > Press > ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30, 2008 and Provide a Business Update
![]()  | 
Abstract:
ULURU Inc. (Amex: ULU) today announced that it has scheduled a conference call to discuss the second quarter 2008 financial results and provide a general business update on Monday, August 11, 2008 at 10:00 a.m. Eastern Time.
 To participate in the conference call, please dial (800) 357-0498 for international callers dial (850) 429-1388 (access code 9295#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast a replay of the call will be available starting on August 11, 2008 two hours following the end of the call until August 18, 2008 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (800) 695-0697 for international callers dial (402) 220-1472 (access code 9295#).
####
About ULURU Inc.
 ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. 
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 and other reports filed by us with the Securities and Exchange Commission.
For more information, please click here
Contacts:
Contact: Company
     Kerry P. Gray
     President & CEO
     Terry K. Wallberg
     Vice President & CFO
     (214) 905-5145
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press | 
News and information
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Nanomedicine
    New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
    New imaging approach transforms study of bacterial biofilms August 8th, 2025
    Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
    Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
    Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Financial Reports
    Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
    Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Events/Classes
    Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
    A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
    Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
| 
			 | 
	||
| 
			 | 
	||
| The latest news from around the world, FREE | ||
| 
			 | 
	||
| 
			 | 
	||
| Premium Products | ||
| 
			 | 
	||
| 
			Only the news you want to read! 
			 Learn More  | 
		||
| 
			 | 
	||
| 
			Full-service, expert consulting 
			 Learn More  | 
		||
| 
			 | 
	||